Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.42

+1.50 (2.50%)

as of Sep 3, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Sep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

DON'T BUY

Avoided all of the sub-prime catastrophes. Trading close to its fair market value

BUY

Solid operations and good growth prospects.

TOP PICK

Did a great deal with Hancock. Lots of capacity to buy from AIG. They will grow even further. Have a great Asian franchise.

TOP PICK

There is talk that they are looking at bits and pieces of AIG (AIG-N). This would be smart as there are some very profitable pieces internationally and in Canada. Have a depth of people throughout the company. Very reasonable multiple for a long-term holder.

BUY

Huge in the far east. First Canadian insurance company to get into China. Huge growth for them.

BUY

Likes its international diversification. The worry in the short term is the forthcoming change in CEO’s. Has a history of diversifying very well and growing outside of Canada and North America.

BUY

Great well run company. Missed the street on numbers but if you look at the components, they were actually quite good. A lot of great growth prospects in Asia.

HOLD

Canadian insurers sold off in light of the financial crisis but are still showing more solid characteristics than some of the US financials. Multiples have come down that it is now good value.

Wealthica Track your Stocks in your Watch List

DON'T BUY

(Market Call Minute.) Great company. His concern is that when money starts moving back to the banks will it come out of the Lifecos.

DON'T BUY

Performance over the last little while has been less than stellar. Sees a flat line to slightly negative ahead. Doesn’t think market’s worries about insurance companies being the next place for financial problems is over. This company is pretty stable.

SELL

Banks have let go but the 2 major life insurance companies hung on. Sun Life has finally let go and this is the last of the companies that hasn't really set back to a level that he would be comfortable buying.

COMMENT

A superb company. Will continue to do well. Good marketing position in China and will be expanding that fairly rapidly. Good position in the US with John Hancock. Prefers Great West Lifeco (GWO-T) currently.

DON'T BUY

Sitting right on its support level and there is risk of it breaking down through it.

DON'T BUY

The whole of the financial sector is facing a big challenge going forward because of the subprime crisis in the US. Expect the company will do well over the next few years but can't see strong profit growth.

TOP PICK

When you can buy this under $40, it represents excellent value. One of the best managed and capitalized financial institutions in Canada. Sees them earning roughly $3 a share this year and about $3.30-$3.40 next year. ROE is the highest in the insurance group in between 16% and 18%.

Showing 1,711 to 1,725 of 2,284 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)